Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
3X FLAG Peptide: From Tag to Translational Tool
2026-09-16
A mechanistic and strategic guide to using the 3X (DYKDDDDK) Peptide in recombinant protein purification, immunodetection, structural biology, and translational assay development, with human SPFH complexes as an architecture-aware case study.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-09-16
The 2024 Development study establishes SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary-cilium formation, neural progenitor survival, and brain development. By combining a mouse model with human SMPD4-deficient induced pluripotent stem cells and a ceramide-rescue experiment, the work connects SMPD4 loss to cerebellar hypoplasia, microcephaly-related phenotypes, and developmental brain disease.
-
Oxaliplatin Workflows for DNA-Damage Research
2026-09-15
Build reproducible Oxaliplatin assays for DNA adduct formation, apoptosis, drug resistance, and tumor-model response. This practical guide combines solution handling, cell-based dose finding, mechanistic controls, and ABCB1-focused readouts to distinguish cytotoxicity from altered drug transport.
-
Müller Cell PEDF Controls Retinal Neuron Survival
2026-09-15
The 2026 study by Younis and colleagues identifies Müller cells as an essential intermediary in angiopoietin-regulated retinal neuron survival. Its experiments connect Ang-1 and Ang-2 activity with Müller cell Tie-2/PI3K/Akt signaling, PEDF production, and PEDF-receptor-dependent neuronal protection, providing a mechanistic framework for retinal neurovascular research.
-
Dasatinib Monohydrate Assay Guide
2026-09-14
Learn how Dasatinib Monohydrate, SKU B5954, can support reproducible kinase-inhibitor studies across viability, proliferation, cytotoxicity, and CML models. This scenario-based guide connects product formulation data with practical controls, concentration-response design, NET-related interpretation, and vendor-selection criteria.
-
Decitabine as a Causality Probe in Gastric Cancer
2026-09-14
Decitabine (5-Aza-2'-deoxycytidine) can do more than reduce DNA methylation: it can help test whether infection-associated silencing of HNF4A is functionally linked to gastric cancer progression. This article presents a causality-focused framework for cancer epigenetics, tumor suppressor gene reactivation, and solid tumor epigenetic studies.
-
SIRT1–PGC-1α–TFAM Signaling in Prion Stress
2026-09-13
Zhao et al. show that prion peptide-induced mitochondrial injury in N2a cells is associated with reduced SIRT1 abundance and activity, impaired mitochondrial biogenesis, and apoptosis. The study identifies a SIRT1–PGC-1α–TFAM pathway through which SIRT1 activation, including pharmacological activation by Resveratrol, can restore mitochondrial function in this cellular model.
-
NADH as a Redox Decision Point in Cell Research
2026-09-12
NADH is more than an energy-transfer coenzyme: its relationship with NAD⁺ provides a framework for interpreting mitochondrial, metabolic, and disease-model data. This article translates NADH redox biology into practical assay decisions, controls, and research applications.
-
Concanavalin A Targets Conserved Coronavirus Glycans
2026-09-11
Guo and colleagues identify two phylogenetically conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad antiviral vulnerability for concanavalin A. By combining fusion, pseudovirus, authentic-virus, biochemical, and mouse studies, the work links glycan recognition to impaired spike activation rather than rapidly evolving receptor-binding epitopes.
-
CLK2 Drives Platinum Resistance in Ovarian Cancer
2026-09-11
A 2024 study identifies CLK2 as a functional determinant of platinum resistance in ovarian cancer, linking CLK2 activity to BRCA1 Ser1423 phosphorylation and enhanced DNA damage repair. The findings establish a preclinical rationale for investigating CLK2-directed strategies while highlighting the need to distinguish CLK2 biology from broader Cdc2-like kinase and splicing effects.
-
Ibrutinib (PCI-32765): BTK Assay Design Guide
2026-09-10
Explore how Ibrutinib (PCI-32765) converts BTK biology into rigorous B-cell assays, from covalent pathway inhibition to CLL and autoimmune disease models. This guide also extracts transferable assay-design lessons from an Alzheimer’s disease study without conflating its findings with BTK pharmacology.
-
Decitabine and HNF4A: Mapping Epigenetic Rescue
2026-09-10
Decitabine (5-Aza-2'-deoxycytidine) can do more than reduce methylation globally. This article shows how to use infection-linked HNF4A silencing as a model for designing locus-aware cancer epigenetics experiments and distinguishing tumor suppressor gene reactivation from nonspecific cytotoxicity.
-
EPZ5676: From H3K79 Control to Immune Signaling
2026-09-09
Explore how EPZ5676, a highly selective DOT1L inhibitor, connects H3K79 methylation inhibition with leukemia biology and emerging innate immune mechanisms. This evidence-focused guide translates biochemical potency into better assay design while defining the limits of cross-disease interpretation.
-
Trelagliptin, RUNX2, and Osteoblast Differentiation
2026-09-09
The reference study identifies a previously underexplored bone-related action of trelagliptin: promotion of osteoblastic differentiation and mineralization in MC3T3-E1 cells through an AMPK–RUNX2-associated mechanism. These findings connect a long-acting DPP-4 inhibitor used in type 2 diabetes treatment with a potential osteogenic application, while remaining preliminary because the work was conducted in a single in vitro model.
-
Kanamycin Sulfate for Selection and RNA Workflows
2026-09-08
Use Kanamycin Sulfate to build a reliable bacterial selection workflow, then connect that upstream control to modern circular RNA purification strategies. This guide separates validated product specifications from practical starting conditions and shows where selection ends—and ultrafiltration begins.